Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Current situation of nucleoside reverse transcriptase inhibitors].

¹Laboratoire ABBOTT, 12, rue de la Couture, SILIC 233, 94528 Rungis Cedex.

Annales De Medecine Interne

|August 3, 2000

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prospective one-year bone loss in treatment-naïve HIV+ men and women on single or multiple drug HIV therapies.

Bone·2011

Same author

Peripheral T-cell lymphoma or Hodgkin's disease in a HIV seropositive patient: a histopathological study.

Histology and histopathology·1989

Same author

[New antiparasitic drugs].

Annales de dermatologie et de venereologie·1988

See all related articles

Nucleosidic reverse transcriptase inhibitors are key in HIV treatment. Understanding viral adaptation and drug toxicity improves their safe and effective use in combination therapy.

Area of Science:

Pharmacology
Virology
Infectious Diseases

Context:

Nucleosidic reverse transcriptase inhibitors (NRTIs) represent the primary drug class for managing Human Immunodeficiency Virus (HIV) infection.
Recent advancements provide insights into viral resistance mechanisms and NRTI-associated toxicities.

Purpose:

To review the current understanding of NRTI mechanisms, viral adaptation, and toxicity.
To highlight the ongoing importance of NRTIs in contemporary HIV treatment regimens.

Summary:

NRTIs were the first approved antiretroviral agents for HIV treatment.
Complex viral adaptation pathways necessitate ongoing research for optimized therapeutic strategies.
Understanding NRTI toxicity is crucial for enhancing patient safety and long-term treatment adherence.

Related Experiment Videos

Impact:

Improved management of HIV disease through better understanding of viral resistance.
Safer utilization of NRTIs due to a clearer grasp of their toxicological profiles.
Sustained efficacy and tolerability of NRTIs solidify their role in multi-drug HIV regimens.